Current pathogen detection methods suffer from excessive delays between sampling and results. Reducing this latency enables immediate clinical intervention and real-time field monitoring.

Current methods for assessing gene expression or therapeutic delivery in the brain require physical penetration of the blood-brain barrier or skull. Non-invasive alternatives eliminate surgical risks and localized tissue damage while providing longitudinal data.